[go: up one dir, main page]

AU6858100A - Increased production of interferon-alpha - Google Patents

Increased production of interferon-alpha

Info

Publication number
AU6858100A
AU6858100A AU68581/00A AU6858100A AU6858100A AU 6858100 A AU6858100 A AU 6858100A AU 68581/00 A AU68581/00 A AU 68581/00A AU 6858100 A AU6858100 A AU 6858100A AU 6858100 A AU6858100 A AU 6858100A
Authority
AU
Australia
Prior art keywords
interferon
alpha
increased production
production
increased
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU68581/00A
Inventor
W.C. Au
Paula Marie Pitha-Rowe
Wen S. Yeow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU6858100A publication Critical patent/AU6858100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU68581/00A 1999-09-03 2000-09-01 Increased production of interferon-alpha Abandoned AU6858100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9920906 1999-09-03
GBGB9920906.6A GB9920906D0 (en) 1999-09-03 1999-09-03 Increased production of interferon-a
PCT/GB2000/003367 WO2001018039A2 (en) 1999-09-03 2000-09-01 INCREASED PRODUCTION OF INTERFERON-$g(a)

Publications (1)

Publication Number Publication Date
AU6858100A true AU6858100A (en) 2001-04-10

Family

ID=10860342

Family Applications (1)

Application Number Title Priority Date Filing Date
AU68581/00A Abandoned AU6858100A (en) 1999-09-03 2000-09-01 Increased production of interferon-alpha

Country Status (3)

Country Link
AU (1) AU6858100A (en)
GB (1) GB9920906D0 (en)
WO (1) WO2001018039A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2879427A1 (en) 2012-07-20 2014-01-23 La Trobe University Method of diagnosis and treatment
GB201505382D0 (en) 2015-03-29 2015-05-13 Svanborg Catharina Novel therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0626448A3 (en) * 1993-05-26 1998-01-14 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Process for preparing and purifying alpha-interferon
CA2234588A1 (en) * 1998-04-07 1999-10-07 John Hiscott Virus induced phosphorylation of interferon regulatory factor-3

Also Published As

Publication number Publication date
GB9920906D0 (en) 1999-11-10
WO2001018039A3 (en) 2001-05-25
WO2001018039A2 (en) 2001-03-15

Similar Documents

Publication Publication Date Title
AU3867400A (en) Methods of using bioelastomers
AU1890300A (en) Novel interferon-alpha
AU3967000A (en) Beta-lactam production
AU6359400A (en) Production of aliphatic fluorocarbons
AU4288900A (en) Production of polyethylene
AU3553400A (en) Use and production of polypropylene
HUP0202519A3 (en) Production of proteins
AU6344698A (en) Production of polysuccinimide
AU2982000A (en) Preparation of 9-hydrocarbyl-9-phosphabicyclononanes
AU2001265935A1 (en) Production of biohydrolysates
AU2736499A (en) Production of microparticles
AU5433699A (en) Spacing of tiles
AU3775500A (en) Setting of gemstones
AU1389801A (en) Modification of plants
AU7273000A (en) Novel processes
AU1038501A (en) Novel processes
AU1720501A (en) Methods of producing novel enzymes
AU2207001A (en) Novel compounds and process
AU7711800A (en) Novel uses of 2-bromopalmitate
AU2288301A (en) Production of recombinant organisms
AU6858100A (en) Increased production of interferon-alpha
AU7796300A (en) Tenocyte compositions and production and uses thereof
AU5049800A (en) Manufacture of moulded products
AU2290401A (en) Novel processes
AU5550700A (en) Novel process

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase